Literature DB >> 21941365

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.

E Launay, C Pangault, P Bertrand, F Jardin, T Lamy, H Tilly, K Tarte, C Bastard, T Fest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21941365     DOI： 10.1038/leu.2011.266

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  34 in total

1.  Follicular lymphomas: a tapestry of common and contrasting threads.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

2.  Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Authors:  Ambrus Gángó; Bence Bátai; Martin Varga; Dóra Kapczár; Gergő Papp; Márta Marschalkó; Enikő Kuroli; Tamás Schneider; Judit Csomor; András Matolcsy; Csaba Bödör; Ágota Szepesi
Journal:  Virchows Arch       Date:  2018-06-01       Impact factor: 4.064

Review 3.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

Review 4.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

5.  Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.

Authors:  Roch Houot; Philippe Gaulard; Robert Schreiber; Ira Mellman; Olivier Lambotte; Pierre G Coulie; Thierry Fest; Alan Korman; Ronald Levy; Margaret Shipp; Karin Tarte; Holbrook Kohrt; Aurélien Marabelle; Stephen Ansell; Hervé Watier; Andrea van Elsas; Arun Balakumaran; Frederick Arce Vargas; Sergio A Quezada; Gilles Salles; Daniel Olive
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

6.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

7.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

Review 8.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.

Authors:  Idoia Martin-Guerrero; Itziar Salaverria; Birgit Burkhardt; Monika Szczepanowski; Michael Baudis; Susanne Bens; Laurence de Leval; Africa Garcia-Orad; Heike Horn; Jasmin Lisfeld; Shoji Pellissery; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

Review 10.  Lymphotoxin network pathways shape the tumor microenvironment.

Authors:  Ryan L Bjordahl; Christian Steidl; Randy D Gascoyne; Carl F Ware
Journal:  Curr Opin Immunol       Date:  2013-01-20       Impact factor: 7.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.